Free Trial
ASX:ANN

Ansell (ANN) Stock Price, News & Analysis

Ansell logo

About Ansell Stock (ASX:ANN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
512,039 shs
Average Volume
N/A
Market Capitalization
$3.33 billion
P/E Ratio
39.82
Dividend Yield
2.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Receive ANN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ansell and its competitors with MarketBeat's FREE daily newsletter.

ANN Stock News Headlines

[INSIDE] Elon’s Next Move Could Send This AI Stock Soaring
Missed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.
See More Headlines

ANN Stock Analysis - Frequently Asked Questions

Ansell Limited (ASX:ANN) released its quarterly earnings results on Monday, August, 12th. The company reported $0.83 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by $0.25. Ansell had a trailing twelve-month return on equity of 4.42% and a net margin of 4.72%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ansell investors own include Teradyne (TER), Abbott Laboratories (ABT), Agree Realty (ADC), Allied Gaming & Entertainment (AGAE), AGL Energy (AGL), ANZ Group (Anz) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
8/12/2019
Ex-Dividend for 3/5 Dividend
2/13/2025
Record date for 3/5 Dividend
3/05/2025
Dividend Payable
3/05/2025
Today
5/23/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Retail
Current Symbol
ASX:ANN
CIK
N/A
Fax
N/A
Employees
4,250
Year Founded
N/A

Profitability

Trailing P/E Ratio
39.82
Forward P/E Ratio
N/A
P/E Growth
-14.4
Net Income
$76.50 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.62 billion
Price / Cash Flow
10.58
Book Value
A$14.37 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$3.33 billion
Optionable
Not Optionable
Beta
0.46
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:ANN) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners